Cara Therapeutics Announces Publication of Difelikefalin (KORSUVA™ Injection) KALM™-1 Phase 3 Trial Results in the New England Journal of Medicine

Ads

You May Also Like

CytomX Announces First Quarter 2016 Financial Results

SOUTH SAN FRANCISCO, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

Karolinska Development’s Chairman of the Board resigns from his position

STOCKHOLM, December 29, 2017. Karolinska Development announces today that the company's Chairman of the ...